Investor Backing & Capital Strength:
A $300 million growth investment from Vista Equity Partners in January 2022 is cited as providing resources to scale products and go‑to‑market. This capital support aligns with subsequent product launches and acquisitions through 2026.
Product Line Growth:
New offerings such as the AI‑powered Operator Console (February 2026) and acquisitions of Twiage (November 2024) and eVideon (August 2025) expand the platform from EMS intake to inpatient smart‑room and operator workflows. These moves extend TigerConnect beyond messaging into broader clinical and patient engagement workflows.
Strong Market Position & Advantage:
Recognition as a Leader in G2’s 2024–2025 reports, continued Leader placement in Gartner’s 2025 CC&C Magic Quadrant, and strong KLAS 2025 signals indicate durable category standing. Company materials also showcase large U.S. health system logos and ongoing momentum claims.
